英文名 | N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)ethanesulfonamide,methanesulfonic acid |
---|---|
英文别名 |
Ethanesulfonamide, N-[4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]-2-(dimethylamino)-, methanesulfonate (1:1)
N-{4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}-2-(dimethylamino)ethanesulfonamide methanesulfonate N-(4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}phenyl)-2-(dimethylamino)ethanesulfonamide methanesulfonate (1:1) N-(4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)-2-(dimethylamino)ethanesulfonamide methanesulfonate |
分子式 | C27H34F2N8O7S2 |
---|---|
分子量 | 684.735 |
精确质量 | 684.195984 |
PSA | 198.73000 |
LogP | 4.76720 |
~% 1246203-36-0 |
文献:Pathway Therapeutics Limited Patent: US2010/249099 A1, 2010 ; Location in patent: Page/Page column 83 ; US 20100249099 A1 |
上游产品 2 | |
---|---|
下游产品 0 |